Your browser doesn't support javascript.
loading
Long-term Survival and Cost-effectiveness Associated With Axicabtagene Ciloleucel vs Chemotherapy for Treatment of B-Cell Lymphoma.
Whittington, Melanie D; McQueen, R Brett; Ollendorf, Daniel A; Kumar, Varun M; Chapman, Richard H; Tice, Jeffrey A; Pearson, Steven D; Campbell, Jonathan D.
Afiliação
  • Whittington MD; Department of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora.
  • McQueen RB; Department of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora.
  • Ollendorf DA; Institute for Clinical and Economic Review, Boston, Massachusetts.
  • Kumar VM; Institute for Clinical and Economic Review, Boston, Massachusetts.
  • Chapman RH; Institute for Clinical and Economic Review, Boston, Massachusetts.
  • Tice JA; Department of Medicine, University of California, San Francisco.
  • Pearson SD; Institute for Clinical and Economic Review, Boston, Massachusetts.
  • Campbell JD; Department of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora.
JAMA Netw Open ; 2(2): e190035, 2019 02 01.
Article em En | MEDLINE | ID: mdl-30794298

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Linfoma de Células B / Antígenos CD19 / Antineoplásicos Tipo de estudo: Etiology_studies / Health_economic_evaluation / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Limite: Humans / Middle aged Idioma: En Revista: JAMA Netw Open Ano de publicação: 2019 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Linfoma de Células B / Antígenos CD19 / Antineoplásicos Tipo de estudo: Etiology_studies / Health_economic_evaluation / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Limite: Humans / Middle aged Idioma: En Revista: JAMA Netw Open Ano de publicação: 2019 Tipo de documento: Article País de publicação: Estados Unidos